Abstract
Orthopaedic surgeons often require highly specialized medical devices, implants, and equipment, which are usually offered by several vendors/companies. This study assesses long-term market trends for orthopaedic medical device companies and examines various implications for healthcare cost. Using S&P Capital IQ, a Wall Street database, financial data were gathered on orthopaedic device companies, ranked by worldwide sales, from 1999 to 2015. Annual sales were aggregated to calculate market share and compounded annual growth rates (CAGRs). Overall, the global orthopaedic device market grew at 12.0% CAGR from 1999 to 2008, before slowing to 2.8% from 2009 to 2015. Between 1999 and 2015, the top 5 companies increased total market share from 52.8 to 62.2%. The orthopaedic device market is not only consolidating under a few dominant players, but also growing at a decreasing rate, both of which signal a maturing industry. These trends are likely to shape patient care and healthcare costs in orthopaedic surgery in years to come.
Similar content being viewed by others
References
Gill PS (2013) Technological innovation and its effect on public health in the United States. J Multidiscip Healthc 6:31–40. https://doi.org/10.2147/JMDH.S34810
Sorenson C, Drummond M, Bhuiyan Khan B (2013) Medical technology as a key driver of rising health expenditure: disentangling the relationship. Clinicoecon Outcomes Res 5:223–234. https://doi.org/10.2147/CEOR.S39634
Aghion P, Bloom N, Blundell R et al (2005) Competition and Innovation: an inverted-U relationship. Q J Econ 120:701–728. https://doi.org/10.1093/qje/120.2.701
Ng M, Song S, Piuzzi NS et al (2017) Stem cell industry update: 2012–2016 reveals accelerated investment, but market capitalization and earnings lag. Cytotherapy 19:1131–1139. https://doi.org/10.1016/j.jcyt.2017.07.006
McElroy M, Pivec R, Issa K et al (2013) The effects of obesity and morbid obesity on outcomes in TKA. J Knee Surg 26:083–088. https://doi.org/10.1055/s-0033-1341407
Etzioni DA, Liu JH, Maggard MA, Ko CY (2003) The aging population and its impact on the surgery workforce. Ann Surg 238:170–177. https://doi.org/10.1097/01.SLA.0000081085.98792.3d
Ulrich SD, Seyler TM, Bennett D et al (2008) Total hip arthroplasties: What are the reasons for revision? Int Orthop 32:597–604. https://doi.org/10.1007/s00264-007-0364-3
Lespasio M, Piuzzi NS, Husni ME et al (2017) Knee osteoarthritis: a primer. Perm J. https://doi.org/10.7812/tpp/16-183
Murray DW, Carr AJ, Bulstrode CJ (1995) Which primary total hip replacement? J Bone Joint Surg Br 77:520–527
Manley MT, Sutton K (2008) Bearings of the future for total hip arthroplasty. J Arthroplasty 23:47–50.e1. https://doi.org/10.1016/j.arth.2008.06.008
BonifacioMark (2016) A Healthy Prognosis for Medtech M&A. In: Orthop. Des. Technol
Okike K, Pollak R, O’Toole RV, Pollak AN (2017) Red–yellow–green. J Bone Jt Surg 99:e33. https://doi.org/10.2106/JBJS.16.00271
Wasterlain AS, Melamed E, Bello R et al (2017) The effect of price on surgeons’ choice of implants: a randomized controlled survey. J Hand Surg Am. https://doi.org/10.1016/j.jhsa.2017.05.005
Piuzzi NS, Ng M, Chughtai M et al (2017) The stem-cell market for the treatment of knee osteoarthritis: a patient perspective. J Knee Surg. https://doi.org/10.1055/s-0037-1604443
Company Overview of Orthoworld, Inc. In: Bloomberg. https://www.bloomberg.com/research/stocks/private/snapshot.asp?privcapid=7691589. Accessed 15 June 2018
Poor’s S& S&P Capital IQ. https://www.capitaliq.com/. Accessed 15 June 2018
Phillips CH (2012) S&P Capital IQ. J Bus Finance Librariansh 17:279–286. https://doi.org/10.1080/08963568.2012.685022
Garde D (2012) Analysts: device market growth will outpace pharma by 2018. In: Fierce Biotech. http://www.fiercebiotech.com/medical-devices/analysts-device-market-growth-will-outpace-pharma-by-2018. Accessed 15 June 2018
Cunningham J, Dolan B, Kelly D, Young C (2015) Medical device sectoral overview. The Whitaker Institute, Galway
Steinbrück K (1999) Epidemiologie von Sportverletzungen-25-Jahres-Analyse einer sportorthopädisch-traumatologischen Ambulanz. Sport Sport 13:38–52. https://doi.org/10.1055/s-2007-993313
George J, Piuzzi NS, Ng M et al (2017) Association between body mass index and thirty-day complications after total knee arthroplasty. J Arthroplasty. https://doi.org/10.1016/j.arth.2017.09.038
Robinson JC, Pozen A, Tseng S, Bozic KJ (2012) Variability in costs associated with total hip and knee replacement implants. J Bone Joint Surg Am 94:1693–1698. https://doi.org/10.2106/JBJS.K.00355
Grennan M (2013) Price discrimination and bargaining: empirical evidence from medical devices. Am Econ Rev 103:145–177. https://doi.org/10.1257/aer.103.1.145
Murphy J, Gray A, Cooper C et al (2016) Costs, quality of life and cost-effectiveness of arthroscopic and open repair for rotator cuff tears. Bone Joint J 98B:1648–1655. https://doi.org/10.1302/0301-620x.98b12.bjj-2016-0121.r1
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
Dr. Piuzzi has nothing to disclose. Mr. Ng reports personal fees from Thessalus Capital, outside the submitted work; Mr. Song has nothing to disclose. Mr. Bigach has nothing to disclose. Dr. Khlopas has nothing to disclose. Dr. Salas-Vega has nothing to disclose. Dr. Mont reports other from Abbot, other from Cymedica, other from DJ Orthopaedics, other from Johnson & Johnson, other from Mallinckrodt Pharmaceuticals, other from Microport, other from Ongoing Care Solutions, other from OrthoSensor, other from Pacira, other from Peerwell, other from Performance Dynamics, other from Sage, other from Stryker, other from TissueGene, outside the submitted work.
Electronic supplementary material
Below is the link to the electronic supplementary material.
Supplemental Table 1
Market capitalization and annual sales of top 10 orthopaedic medical device companies by market capitalization 1999 to 2015 (*all numbers in $M) (DOCX 46 kb)
Supplemental Table 2
Since certain companies had reporting segments that did not relate to orthopaedic devices (e.g., Zimmer and Biomet report dental sales), revenue adjustments were made (DOCX 140 kb)
Rights and permissions
About this article
Cite this article
Piuzzi, N.S., Ng, M., Song, S. et al. Consolidation and maturation of the orthopaedic medical device market between 1999 and 2015. Eur J Orthop Surg Traumatol 29, 759–766 (2019). https://doi.org/10.1007/s00590-019-02372-z
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00590-019-02372-z